DUX4, a Zygotic Genome Activator, Is Involved in Oncogenesis and Genetic Diseases - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Ontogenez / Russian Journal of Developmental Biology Année : 2020

DUX4, a Zygotic Genome Activator, Is Involved in Oncogenesis and Genetic Diseases

Résumé

After fertilization, the genome is transcriptionally quiescent to allow zygote reprogramming that relies on the RNA and proteins accumulated in the oocyte and ensures the transition from the differentiated germ cells to a totipotent state. Reprogramming is followed by zygotic genome activation (ZGA). DUX4 gene encoding for a double homeobox transcription factor is one of the key ZGA drivers in humans. Its expression, essential for embryo development, is subject to precise temporal regulation and is normally observed only at early cleavage stages. DUX4 is efficiently silenced in most somatic tissues via numerous epigenetic mechanisms , while its aberrant expression in skeletal muscle causes facioscapulohumeral muscular dystrophy (FSHD). DUX4 expression following chromosomal rearrangements is also observed in a subset of leukemias and sarcomas; it leads to anti-cancer immune activity suppression.
Fichier principal
Vignette du fichier
2020 Karpukhina RJDB E (1).pdf (418.98 Ko) Télécharger le fichier
Origine : Accord explicite pour ce dépôt

Dates et versions

hal-02988675 , version 1 (17-11-2020)

Identifiants

Citer

Anna Karpukhina, Yegor Vassetzky. DUX4, a Zygotic Genome Activator, Is Involved in Oncogenesis and Genetic Diseases. Ontogenez / Russian Journal of Developmental Biology, 2020, 51 (3), pp.176-182. ⟨10.1134/S1062360420030078⟩. ⟨hal-02988675⟩
31 Consultations
283 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More